The Astbury Centre is “understanding life in molecular detail”. In partnership we are working to “understand cardio metabolic disease in molecular detail”
Due to open in 2018, our £40 million Nexus initiative aims to seamlessly connect business to the University’s world-class research, talent and facilities. Through Nexus we will be working to translate our findings for the fastest possible patient benefit.
Our current Impact and Innovation strategy sets out to implement world class research and training by undertaking novel challenges and maximizing research impact through cutting-edge fundamental research, pioneering innovation and technology developments in cardiovascular disease.
We will achieve this by:
Dr Sikha Saha
MCRC Director of Impact and Innovation
Innovative ideas of novel in vitro organ flow system and also developing biophotonic sensor technologies for non-invasive or minimally invasive detection of biomarkers in cardiovascular and metabolic diseases. Read more
Dr Helen Berry
University Academic Fellow in Cardiovascular Regenerative Therapies and Devices
Development of terminal sterilisation strategies for acellular biological scaffolds leading to improved graft safety, availability, and cost effectiveness. Read more
Dr Andrew Smith
Cardiovascular and Exercise Physiology Group
My research is improving our understanding of CSCs' biology. This may allow exploitation of the eCSCs’ abilities to repair heart tissue. Read more
Dr Steven Sourbron
Lecturer in Magnetic Resonance Imaging, Division of Biomedical Imaging
I have developed an MRI method to measure single kidney function which can be integrated in routine MRI scans and can replace two separate nuclear medicine examinations. Read more
Ramzi Ajjan (FRCP, MMed.Sci, PhD)
Associate Professor and Consultant in Diabetes and Endocrinology
The large programme of work designed to improve glycaemic control in patients with diabetes will help to reduce various vascular complications in this population. Read more
Dr Richard Foster
Medicinal Chemistry Group Leader
With collaborators at Leeds and elsewhere we are working on development of new treatments for a range of cardiovascular indications, including hypertension, thrombosis and heart failure. Read more
Dr Richard Cubbon
Senior Lecturer and Honorary Consultant Cardiologist
Using human and preclinical studies, we have identified dysfunction of important growth factor signalling pathways in insulin resistant (pre-diabetic) blood vessels, which limit new blood vessel growth and repair of injured vessels. Read more
Dr Helen Philippou
Understanding mechanisms of thrombosis and development of novel safer antithrombotic therapeutics.
Yorkshire Children's heart surgery unit's future is secure (Yorkshire Evening Post, 08/07/16) After years of controversy, the future of the service at Leeds General Infirmary finally has been secured. NHS bosses have confirmed it will be one of 10 hospitals nationally continuing to provide congenital heart surgery. More information
Vitamin D3 improves heart function A daily dose of vitamin D3 improves heart function in people with chronic heart failure, a five-year University of Leeds research project has found. More information
A fighting chance Life saving stents for heart attacks. More information
The University website has an Impact Resources section, which contains links and descriptions for a variety of different resources to support research impact. Ged Hall (Organisational Development and Professional Learning) can also be contacted if you have any questions, require support, or would like to explore how to develop impact in your area.
Slides from Dr Ged Hall's presentation on 'Writing credible impact sections of grant application' are now available to download.
Further examples of Pathways to Impact can also be found on the Fast Track Impact website.
If you wish to contribute a profile or add information, please contact email@example.com.